Novel transcript, antisense to PRKCQ (ENSG00000288915)

ENSG00000288915 (LOC107984202) encodes a natural antisense transcript (NAT) to the PRKCQ gene. Natural antisense transcripts are a class of long noncoding RNAs transcribed from the opposite DNA strand of another gene—in this case, PRKCQ. These transcripts typically do not code for proteins but can regulate gene expression through various mechanisms, including the formation of RNA duplexes (RNA masking), interference with transcription of the sense gene, modulation of alternative splicing, and recruitment of chromatin-modifying complexes to induce epigenetic changes[3][1]. The precise function and disease relevance of this specific antisense transcript are not characterized in public literature or databases, and it is not known to be directly targetable by currently approved drugs, nor is it considered a canonical therapeutic target. However, natural antisense transcripts as a class are increasingly of interest as regulatory elements and potential targets in diseases where modulation of their sense gene partners (such as PRKCQ) may be warranted[1][3]. Additional context: - PRKCQ encodes protein kinase C theta, a serine/threonine kinase important in T cell signaling, but the antisense transcript does not encode a kinase or receptor.[3] - NATs may modulate the expression of their sense targets in tissue- and context-specific ways, but direct evidence for clinical or physiological implication of this specific locus is not available in the current literature[3][1].

Other names

LOC107984202novel transcript, antisense to PRKCQ